Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM5C | P41229 | 7/20 | 0.51 |
| ▸ | KDM4A | O75164 | 4/20 | 0.51 |
| ▸ | KDM4B | O94953 | 2/20 | 0.51 |
| ▸ | KDM5B | Q9UGL1 | 2/20 | 0.51 |
| ▸ | KDM4C | Q9H3R0 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.40 |
| ▸ | KDM3A | Q9Y4C1 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.36 |
| ▸ | GABRP | O00591 | 1/20 | 0.34 |
| ▸ | GABRD | O14764 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26566973 | 0.84 | GABRP (0.51) | KDM5CKDM4AKDM4BKDM5BKDM4C | |
| SCHEMBL14993600 | 0.83 | MBOAT4 (0.45) | KDM5CKDM4BKDM5BKDM4CKDM4E | |
| SCHEMBL29700435 | 0.80 | KDM4E (0.51) | KDM5CKDM5BKDM4CKDM4EKDM2A | |
| SCHEMBL346941 | 0.80 | KDM4E (0.51) | KDM5CKDM5BKDM4CKDM4EKDM2A | |
| SCHEMBL26567184 | 0.79 | KDM4C (0.37) | KDM5CKDM5BKDM4CKDM4EKDM2A | |
| SCHEMBL29478781 | 0.76 | CYP1A2 (0.42) | KDM5CKDM4BKDM5BKDM4CKDM4E | |
| SCHEMBL22637811 | 0.76 | CYP1A2 (0.42) | KDM5CKDM4BKDM5BKDM4CKDM4E | |
| SCHEMBL22637814 | 0.76 | CYP1A2 (0.42) | KDM5CKDM4BKDM5BKDM4CKDM4E | |
| Lithium Ion SCHEMBL31704956 | 0.73 | KDM5C (0.44) | KDM5CKDM4AKDM4BKDM5BKDM4C | |
| Lithium Ion SCHEMBL31705584 | 0.73 | KDM5C (0.44) | KDM5CKDM4AKDM4BKDM5BKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4251615-B1 | SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN LA ROCHE (CH) | 2025-10-15 | — | — | EP | disclosed |
| EP-4251615-A1 | SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. Hoffmann-La Roche AG (CH) | 2023-10-04 | — | — | EP | disclosed |
| CN-116406362-A | Spiro [3.3] heptane derivatives for the treatment and prevention of hepatitis b virus infection | 豪夫迈·罗氏有限公司 | 2023-07-07 | — | — | CN | disclosed |
| WO-2022112188-A1 | SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2022-06-02 | — | — | WO | disclosed |